Advanced Pharmacology Exam

Advanced Pharmacology Exam

Advanced Pharmacology Exam

Question 1.1. Up to 21% of Asians are ultra-rapid 2D6 metabolizers, leading to: (Points : 1)

A need to monitor drugs metabolized by 2D6 for toxicity        Increased dosages needed of drugs metabolized by 2D6, such as the SSRIs        Decreased conversion of codeine to morphine by CYP 2D6        The need for lowered dosages of drugs, such as beta blockers

Question 2.2. Rifampin is a nonspecific CYP450 inducer that may: (Points : 1)

Lead to toxic levels of rifampin and must be monitored closely        Cause toxic levels of drugs, such as oral contraceptives, when co-administered        Induce the metabolism of drugs, such as oral contraceptives, leading to therapeutic failure        Cause nonspecific changes in drug metabolism

Question 3.3. Inhibition of P-glycoprotein by a drug such as quinidine may lead to: (Points : 1)

Decreased therapeutic levels of quinidine        Increased therapeutic levels of quinidine        Decreased levels of a co-administered drug, such as digoxin, that requires P-glycoprotein for absorption and elimination        Increased levels of a co-administered drug, such as digoxin, that requires P-glycoprotein for absorption and elimination

Question 4.4. Warfarin resistance may be seen in patients with VCORC1 mutation, leading to: (Points : 1)

Toxic levels of warfarin building up        Decreased response to warfarin        Increased risk for significant drug interactions with warfarin        Less risk of drug interactions with warfarin

Question 5.5. Pharmacogenetic testing is required by the Food and Drug Administration (FDA) prior to prescribing: (Points : 1)

Erythromycin        Digoxin        Cetuximab        Rifampin

Question 6.6. Patients who have a poor metabolism phenotype will have: (Points : 1)

Slowed metabolism of a prodrug into an active drug, leading to accumulation of prodrug        Accumulation of inactive metabolites of drugs        A need for increased dosages of medications        Increased elimination of an active drug

Question 7.7. Ultra-rapid metabolizers of drugs may have: (Points : 1)

To have dosages of drugs adjusted downward to prevent drug accumulation        Active drug rapidly metabolized into inactive metabolites, leading to potential therapeutic failure        Increased elimination of active, nonmetabolized drug        Slowed metabolism of a prodrug into an active drug, leading to accumulation of prodrug

Question 8.8. When melatonin is used to induce sleep, the recommendation is the patient: (Points : 1)

Take 10 mg 30 minutes before bed nightly        Take 1 to 5 mg 30 minutes before bed nightly        Not take melatonin more than three nights a week        Combine melatonin with zolpidem (Ambien) for the greatest impact on sleep

Question 9.9. Valerian tea causes relaxation and can be used to help a patient fall asleep. Overdosage of valerian (more than 2.5 gm/dose) may lead to: (Points : 1)

Cardiac disturbances        Central nervous system depression        Respiratory depression        Skin rashes

Question 10.10. The standard dosage of St John’s Wort for the treatment of mild depression is: (Points : 1)

300 mg daily        100 mg three times a day        300 mg three times a day        600 mg three times a day

Question 11.11. Licorice root is a common treatment for dyspepsia. Drug interactions with licorice include: (Points : 1)

Antihypertensives, diuretics, and digoxin        Antidiarrheals, antihistamines, and omeprazole        Penicillin antibiotic class and benzodiazepines        None of the above

Question 12.12. Patients should be warned about the overuse of topical wintergreen oil to treat muscle strains, as overapplication can lead to: (Points : 1)

Respiratory depression        Cardiac disturbance        Salicylates poisoning        Life-threatening rashes

KINDLY ORDER NOW FOR A CUSTOM-WRITTEN, PLAGIARISM-FREE PAPER WITH COMPLETE ANSWERS